“…Many formulations were developed later in different dosage forms to enhance CLOP solubility and bioavailability. A literature search revealed formulating CLOP as IR tablets ( Kavya et al, 2014 , Kumar et al, 2013 ), gastro retentive system as floated tablets ( Rao and Lakshmi, 2014 ), high-density tablets ( Desai and Purohit, 2017 ) or floated osmotic capsules ( Shah and Prajapati, 2019 ), liquisolid compact ( Ali et al, 2021 , Mohammed and Mohammed, 2018 ), micro-emulsion ( Patel et al, 2010 ), nano-suspension ( Jassim and Hussein, 2014 ), oral disintegrating tablets ( Mahrous et al, 2016 ), or fast disintegrating films (Alladi Saritha, 2018 ), and as FDC system ( Huang et al, 2011 , Seo and Han, 2019 ).…”